These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 37296227

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA, Edwards C, Cai RY, Gibbs V.
    Autism Adulthood; 2023 Dec 01; 5(4):389-400. PubMed ID: 38116059
    [Abstract] [Full Text] [Related]

  • 44. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E, Anderson E, Cochrane M, Shirkey BA, Parslow R, Hollingworth W, Mills N, Gaunt D, Treneman-Evans G, Rai M, Macleod J, Kessler D, Pitts K, Cooper S, Loades M, Annaw A, Stallard P, Knoop H, Van de Putte E, Nijhof S, Bleijenberg G, Metcalfe C.
    Health Technol Assess; 2024 Oct 01; 28(70):1-134. PubMed ID: 39485730
    [Abstract] [Full Text] [Related]

  • 45. Breastfeeding or breast milk for procedural pain in neonates.
    Shah PS, Torgalkar R, Shah VS.
    Cochrane Database Syst Rev; 2023 Aug 29; 8(8):CD004950. PubMed ID: 37643989
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Mobility training for increasing mobility and functioning in older people with frailty.
    Treacy D, Hassett L, Schurr K, Fairhall NJ, Cameron ID, Sherrington C.
    Cochrane Database Syst Rev; 2022 Jun 30; 6(6):CD010494. PubMed ID: 35771806
    [Abstract] [Full Text] [Related]

  • 48. Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.
    Mease PJ, Ferrante SA, Shiff NJ, Fitzgerald TP, Chakravarty SD, Walsh JA.
    Adv Ther; 2024 Dec 02. PubMed ID: 39621228
    [Abstract] [Full Text] [Related]

  • 49. Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada.
    Lu J, Vulesevic B, Burchell AN, Singer J, Needham J, Yang Y, Qian H, Chambers C, Samji H, Colmegna I, Del Canto S, Godin GH, Habanyama M, Hui SSC, Kroch A, Mandarino E, Margolese S, Martin C, Owino M, Lau E, Mohammadi T, Zhang W, Pelaez S, Kovacs C, Benko E, Cooper CL, Anis AH, Costiniuk CT, COVAXHIV Study Group.
    Vaccine X; 2024 Dec 02; 21():100566. PubMed ID: 39582795
    [Abstract] [Full Text] [Related]

  • 50. Emotional literacy programme in special schools for children with a learning disability in England: the ZF-SEND feasibility RCT.
    Stenfert Kroese B, Unwin G, Hastings R, Jahoda A, McNamara R, Gillespie D, Segrott J, Ingarfield K, Gianatsi M, Randell E, Mather Z, Barrett B, Ganguli P, Rose J, Sahle M, Warren E, Da Cruz N.
    Public Health Res (Southampt); 2024 Dec 02; 12(15):1-105. PubMed ID: 39641743
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Correction to "Increased expression of desmin and vimentin reduces bladder smooth muscle contractility via JNK2".
    FASEB J; 2024 Dec 15; 38(23):e70219. PubMed ID: 39652015
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ, Karner C, Jhita T, Barton S, Marceniuk G, Yiu ZZN, Wittmann M.
    Health Technol Assess; 2024 Jan 15; 28(4):1-113. PubMed ID: 38343072
    [Abstract] [Full Text] [Related]

  • 60. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
    Jonker D, Rumble RB, Maroun J, Gastrointestinal Cancer Disease Site Groupof Cancer Care Ontario’s Program in Evidence-Based Care.
    Curr Oncol; 2006 Oct 15; 13(5):173-84. PubMed ID: 22792014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.